The expression and significance of p4E-BP1/4E-BP1 in prostate cancer.
Kai-Yun WangKe-Jie WangQi MaPublished in: Journal of clinical laboratory analysis (2022)
These findings suggest that p4E-BP1 is a potential biomarker and therapy target for prostate cancer, and patients with high expressions of p4E-BP1 may benefit from Everolimus treatment.